Athanor Capital, LP Inhibrx, Inc. Transaction History

Athanor Capital, LP

  • $24.6 Million
  • Q4 2022

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$16.27 - $41.26 $106,942 - $271,201
-6,573 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$15.96 - $50.0 $104,905 - $328,650
6,573 New
6,573 $217,000

Others Institutions Holding INBX

# of Institutions
2
Shares Held
25.3K
Call Options Held
0
Put Options Held
0
View Full List

About Inhibrx, Inc.

INBX Quotes by TradingView
  • Ticker INBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,057,700
  • Market Cap $626M
  • Description
  • Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...
More about INBX
Track This Portfolio

Track Athanor Capital, LP Portfolio

Follow Athanor Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Athanor Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email